Stock listing
NASDAQ:GEVA Synageva BioPharma Corp Stock
Follow Synageva BioPharma Corp into a list and get an email when it puts out news.
Last close · NASDAQ:GEVA
$238.60 USD
Close on Jun 22, 2015 · No longer trades
- Lowest – highest close
- $4.30 – $238.60 USDSince Jan 4, 1999 · lowest Jan 20, 2009 · highest Jun 22, 2015
Delisted NASDAQ:GEVA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:GEVA
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Synageva BioPharma Corp on 6ix
- Decks
- 6 decks · latest Jun 5, 2015
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (June 2015) | Merger or acquisition | 31 slides | Jun 5, 2015 |
| Merger or Acquisition (May 2015) | Merger or acquisition | 30 slides | May 11, 2015 |
| Merger or Acquisition (May 2015) | Merger or acquisition | 20 slides | May 6, 2015 |
| Trimeris — Merger or Acquisition (September 2011) | Merger or acquisition | 32 slides | Sep 7, 2011 |
| Trimeris — Merger or Acquisition (July 2011) | Merger or acquisition | 19 slides | Jul 27, 2011 |
| Trimeris — Merger or Acquisition (July 2011) | Merger or acquisition | 32 slides | Jul 20, 2011 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mark Alan Goldberg Other companies: Blueprint Medicines Corp (Director · Since at least Jun 25, 2015); Audentes Therapeutics Inc (Director · Dec 11, 2017 – Jan 15, 2020 · Past); aTyr Pharma, Inc. (Director · May 6, 2015 – May 9, 2017 · Past); Crescent Biopharma, Inc. (Director · Jul 8, 2014 – May 1, 2024 · Past); Aceragen Inc. (Director · Jan 7, 2014 – Jun 23, 2022 · Past); ImmunoGen Inc (Director · Nov 8, 2011 – Feb 12, 2024 · Past) | EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past |
| Glen Williams | SVP, Technical Operations · Sep 24, 2012 – Jun 22, 2015 · Past |
Log in to ask 6ix AI your own questions about Synageva BioPharma Corp.